Cancer Research Donn Young Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rudland, P. S.
Right arrow Articles by Barraclough, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rudland, P. S.
Right arrow Articles by Barraclough, R.
[Cancer Research 60, 1595-1603, March 15, 2000]
© 2000 American Association for Cancer Research

Clinical Investigations

Prognostic Significance of the Metastasis-inducing Protein S100A4 (p9Ka) in Human Breast Cancer1

Philip S. Rudland2, Angela Platt-Higgins, Christine Renshaw, Christopher R. West, John H. R. Winstanley3, Lynne Robertson and Roger Barraclough

School of Biological Sciences [P. S. R., A. P-H., L. R., R. B.], Cancer Tissue Bank Research Centre [P. S. R., C. R.], and Department of Public Health [C. R. W.], University of Liverpool and Breast Unit, Royal Liverpool University Hospital [J. H. R. W.], Liverpool L69 3BX, United Kingdom

The calcium-binding protein S100A4 is capable of inducing metastasis in rodent models for breast cancer. We now show that rabbit antibodies to recombinant rat S100A4 recognize specifically human S100A4 using Western blotting techniques and use them to assess the prognostic significance of S100A4 in primary tumors from a group of 349 patients treated between 1976 and 1982 for stage I and stage II breast cancer. The antibody stains normal breast tissue heterogeneously, but stains positively 41% of the carcinomas, leaving the remaining 59% as negatively stained. In addition to the carcinoma cells, some host stromal cells and lymphocytes are also stained, but these have been discounted in subsequent analyses. There is an association of staining of carcinomas for S100A4 with some tumor variables considered to be associated with poor prognosis for patients: tumor present in axillary lymph nodes (borderline P = 0.058), staining for c-erbB-3 (P = 0.002), cathepsin D (P = 0.024), and c-erbB-2 (P = 0.048). The association of staining for S100A4 with patient survival has been evaluated using life tables and analyzed using generalized Wilcoxon statistics. Eighty percent of the S100A4-negative patients but only 11% of the S100A4-positive patients are alive after 19 years of follow-up, and this association is highly significant (P < 0.0001); the former have a median survival of >228 months and the latter 47 months. The other tumor variables that show significant association with survival time are nodal status (P < 0.0001), tumor size (P = 0.0035), histological grade (P = 0.013), staining for c-erbB-2 (P = 0.0015), estrogen receptor (P = 0.028), and p53 (P = 0.032). Analysis of the association of patients with carcinomas staining for S100A4 and their survival in subgroups defined by these other tumor variables shows that in each subgroup, staining for S100A4 is associated with poorer survival. Patients whose tumors stain for S100A4 and possess involved lymph nodes (P < 0.0001), which are fixed to the chest wall (P = 0.015) or which stain for c-erbB-2 (P = 0.050), show a significant reduction in survival times over those with only S100A4-staining tumors. Patients with involved lymph nodes, or staining for c-erbB-2 in the S100A4-negative group fail to show any significant reduction in survival times. Multivariate regression analysis for 137 patients shows that staining for S100A4 is most highly correlated with patient deaths (P < 0.0001), but involved lymph nodes (P = 0.001), fixed tumors (P = 0.0002), and high histological grade (P = 0.022) are also significant independent prognostic variables. These results suggest that in this group of patients, the metastasis-inducing protein S100A4 is most tightly correlated with patient demise.




This article has been cited by other articles:


Home page
 Am. J. Pathol.Home page
D. L. Barraclough, A. Platt-Higgins, S. de Silva Rudland, R. Barraclough, J. Winstanley, C. R. West, and P. S. Rudland
The Metastasis-Associated Anterior Gradient 2 Protein Is Correlated with Poor Survival of Breast Cancer Patients
Am. J. Pathol., November 1, 2009; 175(5): 1848 - 1857.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
T. H. Kim, H. I. Kim, Y. H. Soung, L. A. Shaw, and J. Chung
Integrin ({alpha}6{beta}4) Signals Through Src to Increase Expression of S100A4, a Metastasis-Promoting Factor: Implications for Cancer Cell Invasion
Mol. Cancer Res., October 1, 2009; 7(10): 1605 - 1612.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Arumugam, V. Ramachandran, K. F. Fournier, H. Wang, L. Marquis, J. L. Abbruzzese, G. E. Gallick, C. D. Logsdon, D. J. McConkey, and W. Choi
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
Cancer Res., July 15, 2009; 69(14): 5820 - 5828.
[Abstract] [Full Text] [PDF]

Home page
 Anticancer ResHome page
M. TSUNA, S.-I. KAGEYAMA, J. FUKUOKA, H. KITANO, Y. DOKI, H. TEZUKA, and H. YASUDA
Significance of S100A4 as a Prognostic Marker of Lung Squamous Cell Carcinoma
Anticancer Res, July 1, 2009; 29(7): 2547 - 2554.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
T. M. Ismail, D. G. Fernig, P. S. Rudland, C. J. Terry, G. Wang, and R. Barraclough
The basic C-terminal amino acids of calcium-binding protein S100A4 promote metastasis
Carcinogenesis, December 1, 2008; 29(12): 2259 - 2266.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
A. Moon, H.-Y. Yong, J.-I. Song, D. Cukovic, S. Salagrama, D. Kaplan, D. Putt, H. Kim, A. Dombkowski, and H.-R. C. Kim
Global Gene Expression Profiling Unveils S100A8/A9 as Candidate Markers in H-Ras-Mediated Human Breast Epithelial Cell Invasion
Mol. Cancer Res., October 1, 2008; 6(10): 1544 - 1553.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E. Spiekerkoetter, C. M. Alvira, Y.-M. Kim, A. Bruneau, K. L. Pricola, L. Wang, N. Ambartsumian, and M. Rabinovitch
Reactivation of {gamma}HV68 induces neointimal lesions in pulmonary arteries of S100A4/Mts1-overexpressing mice in association with degradation of elastin
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L276 - L289.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
P.-S. Chen, M.-Y. Wang, S.-N. Wu, J.-L. Su, C.-C. Hong, S.-E. Chuang, M.-W. Chen, K.-T. Hua, Y.-L. Wu, S.-T. Cha, et al.
CTGF enhances the motility of breast cancer cells via an integrin-{alpha}vbeta3-ERK1/2-dependent S100A4-upregulated pathway
J. Cell Sci., June 15, 2007; 120(12): 2053 - 2065.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. de Silva Rudland, L. Martin, C. Roshanlall, J. Winstanley, S. Leinster, A. Platt-Higgins, J. Carroll, C. West, R. Barraclough, and P. Rudland
Association of S100A4 and Osteopontin with Specific Prognostic Factors and Survival of Patients with Minimally Invasive Breast Cancer
Clin. Cancer Res., February 15, 2006; 12(4): 1192 - 1200.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Wang, A. Platt-Higgins, J. Carroll, S. de Silva Rudland, J. Winstanley, R. Barraclough, and P. S. Rudland
Induction of Metastasis by S100P in a Rat Mammary Model and Its Association with Poor Survival of Breast Cancer Patients
Cancer Res., January 15, 2006; 66(2): 1199 - 1207.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. C. Garrett, K. M. Varney, D. J. Weber, and A. R. Bresnick
S100A4, a Mediator of Metastasis
J. Biol. Chem., January 13, 2006; 281(2): 677 - 680.
[Full Text] [PDF]

Home page
 Cancer Res.Home page
I. Krop, A. Marz, H. Carlsson, X. Li, N. Bloushtain-Qimron, M. Hu, R. Gelman, M. S. Sabel, S. Schnitt, S. Ramaswamy, et al.
A Putative Role for Psoriasin in Breast Tumor Progression
Cancer Res., December 15, 2005; 65(24): 11326 - 11334.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Semov, M. J. Moreno, A. Onichtchenko, A. Abulrob, M. Ball, I. Ekiel, G. Pietrzynski, D. Stanimirovic, and V. Alakhov
Metastasis-associated Protein S100A4 Induces Angiogenesis through Interaction with Annexin II and Accelerated Plasmin Formation
J. Biol. Chem., May 27, 2005; 280(21): 20833 - 20841.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
B. Grum-Schwensen, J. Klingelhofer, C. H. Berg, C. El-Naaman, M. Grigorian, E. Lukanidin, and N. Ambartsumian
Suppression of Tumor Development and Metastasis Formation in Mice Lacking the S100A4(mts1) Gene
Cancer Res., May 1, 2005; 65(9): 3772 - 3780.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Liu, P. S. Rudland, D. R. Sibson, A. Platt-Higgins, and R. Barraclough
Human Homologue of Cement Gland Protein, a Novel Metastasis Inducer Associated with Breast Carcinomas
Cancer Res., May 1, 2005; 65(9): 3796 - 3805.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Saleem, V. M. Adhami, N. Ahmad, S. Gupta, and H. Mukhtar
Prognostic Significance of Metastasis-Associated Protein S100A4 (Mts1) in Prostate Cancer Progression and Chemoprevention Regimens in an Autochthonous Mouse Model
Clin. Cancer Res., January 1, 2005; 11(1): 147 - 153.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
B. Schmidt-Hansen, J. Klingelhofer, B. Grum-Schwensen, A. Christensen, S. Andresen, C. Kruse, T. Hansen, N. Ambartsumian, E. Lukanidin, and M. Grigorian
Functional Significance of Metastasis-inducing S100A4(Mts1) in Tumor-Stroma Interplay
J. Biol. Chem., June 4, 2004; 279(23): 24498 - 24504.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. El-Tanani, A. Platt-Higgins, P. S. Rudland, and F. C. Campbell
Ets Gene PEA3 Cooperates with {beta}-Catenin-Lef-1 and c-Jun in Regulation of Osteopontin Transcription
J. Biol. Chem., May 14, 2004; 279(20): 20794 - 20806.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. J. Kim and D. M. Helfman
Characterization of the Metastasis-associated Protein, S100A4: ROLES OF CALCIUM BINDING AND DIMERIZATION IN CELLULAR LOCALIZATION AND INTERACTION WITH MYOSIN
J. Biol. Chem., August 8, 2003; 278(32): 30063 - 30073.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
N. Sato, A. Maitra, N. Fukushima, N. T. van Heek, H. Matsubayashi, C. A. Iacobuzio-Donahue, C. Rosty, and M. Goggins
Frequent Hypomethylation of Multiple Genes Overexpressed in Pancreatic Ductal Adenocarcinoma
Cancer Res., July 15, 2003; 63(14): 4158 - 4166.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
E. D. Emberley, Y. Niu, C. Njue, E. V. Kliewer, L. C. Murphy, and P. H. Watson
Psoriasin (S100A7) Expression Is Associated with Poor Outcome in Estrogen Receptor-negative Invasive Breast Cancer
Clin. Cancer Res., July 1, 2003; 9(7): 2627 - 2631.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Xue, D. Plieth, C. Venkov, C. Xu, and E. G. Neilson
The Gatekeeper Effect of Epithelial-Mesenchymal Transition Regulates the Frequency of Breast Cancer Metastasis
Cancer Res., June 15, 2003; 63(12): 3386 - 3394.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. D. Emberley, Y. Niu, E. Leygue, L. Tomes, R. D. Gietz, L. C. Murphy, and P. H. Watson
Psoriasin Interacts with Jab1 and Influences Breast Cancer Progression
Cancer Res., April 15, 2003; 63(8): 1954 - 1961.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. J. Adam, R. Boyd, K. L. Tyson, G. C. Fletcher, A. Stamps, L. Hudson, H. R. Poyser, N. Redpath, M. Griffiths, G. Steers, et al.
Comprehensive Proteomic Analysis of Breast Cancer Cell Membranes Reveals Unique Proteins with Potential Roles in Clinical Cancer
J. Biol. Chem., February 14, 2003; 278(8): 6482 - 6489.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. Hernan, R. Fasheh, C. Calabrese, A. J. Frank, K. H. Maclean, D. Allard, R. Barraclough, and R. J. Gilbertson
ERBB2 Up-Regulates S100A4 and Several other Prometastatic Genes in Medulloblastoma
Cancer Res., January 1, 2003; 63(1): 140 - 148.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. Gupta, T. Hussain, G. T. MacLennan, P. Fu, J. Patel, and H. Mukhtar
Differential Expression of S100A2 and S100A4 During Progression of Human Prostate Adenocarcinoma
J. Clin. Oncol., January 1, 2003; 21(1): 106 - 112.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pathol.Home page
C L Li, V Martinez, B He, A Lombet, and B Perbal
A role for CCN3 (NOV) in calcium signalling
Mol. Pathol., August 1, 2002; 55(4): 250 - 261.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Endo, K. Takenaga, T. Kanno, H. Satoh, and S. Mori
Methionine Aminopeptidase 2 Is a New Target for the Metastasis-associated Protein, S100A4
J. Biol. Chem., July 12, 2002; 277(29): 26396 - 26402.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. S. Rudland, A. Platt-Higgins, M. El-Tanani, S. de Silva Rudland, R. Barraclough, J. H. R. Winstanley, R. Howitt, and C. R. West
Prognostic Significance of the Metastasis-associated Protein Osteopontin in Human Breast Cancer
Cancer Res., June 1, 2002; 62(12): 3417 - 3427.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Li, X. Yu, W. Pan, and R. H. Unger
Gene expression profile of rat adipose tissue at the onset of high-fat-diet obesity
Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1334 - E1341.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Kriajevska, M. Fischer-Larsen, E. Moertz, O. Vorm, E. Tulchinsky, M. Grigorian, N. Ambartsumian, and E. Lukanidin
Liprin beta 1, a Member of the Family of LAR Transmembrane Tyrosine Phosphatase-interacting Proteins, Is a New Target for the Metastasis-associated Protein S100A4 (Mts1)
J. Biol. Chem., February 8, 2002; 277(7): 5229 - 5235.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. Levett, P. A. Flecknell, P. S. Rudland, R. Barraclough, D. E. Neal, J. K. Mellon, and B. R. Davies
Transfection of S100A4 Produces Metastatic Variants of an Orthotopic Model of Bladder Cancer
Am. J. Pathol., February 1, 2002; 160(2): 693 - 700.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
L. Mazzucchelli
Protein S100A4: Too Long Overlooked by Pathologists?
Am. J. Pathol., January 1, 2002; 160(1): 7 - 13.
[Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Rosty, T. Ueki, P. Argani, M. Jansen, C. J. Yeo, J. L. Cameron, R. H. Hruban, and M. Goggins
Overexpression of S100A4 in Pancreatic Ductal Adenocarcinomas Is Associated with Poor Differentiation and DNA Hypomethylation
Am. J. Pathol., January 1, 2002; 160(1): 45 - 50.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Grigorian, S. Andresen, E. Tulchinsky, M. Kriajevska, C. Carlberg, C. Kruse, M. Cohn, N. Ambartsumian, A. Christensen, G. Selivanova, et al.
Tumor Suppressor p53 Protein Is a New Target for the Metastasis-associated Mts1/S100A4 Protein. FUNCTIONAL CONSEQUENCES OF THEIR INTERACTION
J. Biol. Chem., June 15, 2001; 276(25): 22699 - 22708.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.